SequelSEC

LifeMD, Inc. LFMD

Services-Offices & Clinics of Doctors of Medicine · CIK 0000948320 · Fiscal year ends 1231

Revenue
$194.06M
Fiscal year ended 2025-12-31
Operating income
-$7.67M
Fiscal year ended 2025-12-31
Free cash flow
$6.41M
Fiscal year ended 2025-12-31

LifeMD, Inc. (LFMD) reported revenue of $194.06M and net income of $14.35M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from LifeMD, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Offices & Clinics of Doctors of Medicine.

Income

LifeMD, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$194.06M$154.82M$152.55M$119.03M$92.88M$37.29M$12.47M$8.32M$3.68M$5.24M
Cost of revenue$27.71M$21.44M$18.90M$18.67M$18.00M$8.86M$2.53M$2.00M$1.02M$1.95M
Gross profit$166.34M$133.38M$133.65M$100.37M$74.88M$28.43M$9.94M$6.33M$2.66M$3.29M
Operating income-$7.67M-$20.40M-$14.49M-$43.45M-$54.30M-$57.82M-$2.89M-$2.06M-$1.23M-$1.17M
Net income$14.35M-$21.41M-$20.60M-$45.54M-$60.90M-$58.65M-$3.14M-$1.24M-$1.21M-$1.11M
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 45.13Mshares 41.20Mshares 33.91Mshares 30.98Mshares 27.01Mshares 14.28Mshares 9.90Mshares 44.19Mshares 41.74Mshares 33.48M
Pretax income-$10.19M-$22.58M-$17.41M-$44.66M-$61.32M-$60.40M-$3.65M-$2.41M-$1.38M-$1.22M
Income tax expense$45.72K$598.00K$428.00K$360.70K$7.70K$122.50K-$122.50K-$124.70KUnavailableUnavailable
Diluted EPS$0.25$-0.60UnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$-0.03$-0.03
Selling, general & administrative$144.01M$128.05M$128.15M$125.33M$122.08M$84.01M$11.31M$7.37MUnavailableUnavailable
General & administrative$57.94M$57.95M$51.69M$46.96M$39.53M$44.96M$2.40M$2.29M$741.95K$1.03M
Selling & marketing$86.07M$70.10M$76.45M$78.37M$82.54M$39.05M$8.92M$5.08MUnavailableUnavailable

Balance

LifeMD, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Cash & equivalentsUnavailable$35.00M$33.15M$3.96M$41.33M$9.18M$1.11M$180.09K$141.38K$182.56K
Total assets$70.41M$76.10M$58.48M$25.67M$49.92M$13.40M$3.45M$2.62M$1.26M$789.82K
Current assets$51.83M$52.37M$42.60M$11.31M$44.92M$12.41M$2.75M$1.61M$1.26M$789.82K
Total liabilities$47.25M$83.65M$52.91M$32.97M$24.10M$14.22M$4.58M$1.80M$640.97KUnavailable
Current liabilities$41.57M$67.40M$34.78M$31.37M$22.83M$13.93M$3.98M$1.19M$640.97K$1.15M
Total equity incl. NCI$23.16M-$7.55M$4.19M-$11.87M$21.71M-$4.48M-$1.13M$819.74K$622.84K-$361.72K
Temporary (mezzanine) equityUnavailableUnavailableUnavailable$4.57M$4.11M$3.66MUnavailableUnavailableUnavailableUnavailable
Inventory$2.77M$2.80M$2.76M$3.70M$1.62M$1.26M$950.06K$1.02M$681.26K$160.27K
Accounts receivable$9.31M$10.46M$6.27M$2.83M$980.06K$997.76K$97.45K$99.05K$128.19K$444.74K
GoodwillUnavailableUnavailableUnavailable$8.00M$0UnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$14.15M$10.90M$11.08M$10.11M$9.06M$10.41MUnavailableUnavailableUnavailableUnavailable

Cash flow

LifeMD, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Operating cash flow$8.28M$17.51M$8.82M-$22.94M-$33.09M-$12.13M$251.41K-$905.52K-$817.22K-$407.91K
Capital expenditures$1.87M$1.46M$203.81K$366.63K$247.36KUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flow$6.91M-$11.54M-$8.73M-$13.91M-$3.40M-$798.14K-$100.00K$141.44KUnavailableUnavailable
Financing cash flow-$13.41M-$4.12M$29.10M-$528.20K$68.64M$21.00M$775.12K$802.79K$776.03K$357.49K
Net change in cash$1.78M$1.86M$29.19M-$37.37M$32.15M$8.07M$926.53K$38.71K-$41.18K-$50.42K
Stock-based compensation$10.50M$12.23M$12.49M$13.73M$12.07M$18.66M$733.22K$273.57K$162.74K$587.99K
Common dividends paid$3.11M$3.11M$3.11M$3.11M$871.48KUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchases$270.00KUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$76.65KUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

LifeMD, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Free cash flow$6.41M$16.05M$8.62M-$23.30M-$33.33MUnavailableUnavailableUnavailableUnavailableUnavailable
Gross margin85.7%86.2%87.6%84.3%80.6%76.2%79.7%76.0%72.4%62.9%
Operating margin-4.0%-13.2%-9.5%-36.5%-58.5%-155.0%-23.2%-24.7%-33.4%-22.4%
FCF margin3.3%10.4%5.6%-19.6%-35.9%UnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenue5.4%7.9%8.2%11.5%13.0%50.0%5.9%3.3%4.4%11.2%
Current ratio1.25x0.78x1.22x0.36x1.97x0.89x0.69x1.35x1.97x0.69x
Revenue YoY growth25.3%1.5%28.2%28.2%149.0%199.1%49.8%126.1%-29.7%Unavailable
Net margin7.4%-13.8%-13.5%-38.3%-65.6%-157.3%-25.2%-14.9%-32.8%-21.1%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenue1.0%0.9%0.1%0.3%0.3%UnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open LFMD in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-06View SEC filing
10-K · Filed 2026-03-10View SEC filing
10-Q · Filed 2025-11-17View SEC filing
10-Q · Filed 2025-08-05View SEC filing
10-Q · Filed 2025-05-06View SEC filing

Companies in the same industry

Reconciliation checks needing review

1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

balance equationreview2023-12-31

Difference 1377109 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.